Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04574583
Title	Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	oropharynx cancer Advanced Solid Tumor head and neck squamous cell carcinoma triple-receptor negative breast cancer head and neck cancer
Therapies	Bintrafusp alfa + FPV-CV301 + MVA-BN-CV301 + SX-682
Age Groups:	adult \| senior
Covered Countries	USA